abstract |
The present invention relates to a compound of formula (I): in which A, R1, R2, and R3 are defined the same as the specification. Also disclosed are (1) a pharmaceutical composition containing such a compound, and (2) a method for treating a cannabinoid receptor-mediated disorder using such a compound. |